インドシアニングリーンの世界市場シェアとランキング、総売上高および需要予測 2025-2031

Indocyanine Green - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

インドシアニングリーンの世界市場シェアとランキング、総売上高および需要予測 2025-2031

商品番号 : SMB-88276

出版社QYResearch
出版年月2025年10月
ページ数111
図表数123
価格タイプシングルユーザライセンス
価格USD 3,950
種別英文調査報告書

インドシアニングリーンの世界市場は、2024年には8,330万米ドルに達すると推定され、2025~2031年の予測期間中に5.0%のCAGRで成長し、2031年までに1億2,100万米ドルに再調整された規模になると予測されています。

インドシアニングリーン(ICG)(CAS番号:3599-32-4)は、心拍出量、肝機能、肝血流の測定などの医療診断、および眼科血管造影に使用されるシアニン色素です。滅菌済みの凍結乾燥緑色粉末で、800nmに吸収ピークを有します。この赤外線は網膜層を透過するため、ICG血管造影ではフルオレセイン血管造影よりも深部の循環パターンを画像化できます。

本レポートは、インドシアニングリーンの世界市場について、総販売量、売上高、価格、主要企業の市場シェアとランキングに焦点を当て、地域・国別、タイプ別、用途別のインドシアニングリーン分析も含め、包括的な分析を提供することを目的としています。

インドシアニングリーン市場の規模、推定値、および予測は、2024年を基準年として、販売量(千NOS)および売上高(百万ドル)の観点から提供され、2020年から2031年までの実績および予測データも含まれています。定量分析と定性分析の両方を用いて、読者が事業/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、インドシアニングリーンに関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。

Report Overview

The global market for Indocyanine Green was estimated to be worth US$ 83.3 million in 2024 and is forecast to a readjusted size of US$ 121 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.

Indocyanine green (ICG) (CAS 3599-32-4), a cyanine dye used in medical diagnostics to determine cardiac output, hepatic function, and liver blood flow, and for ophthalmic angiography. It is a sterile, lyophilized green powder with a peak spectral absorption at 800 nm. These infrared frequencies penetrate retinal layers, allowing ICG angiography to image deeper patterns of circulation than fluorescein angiography.

Europe is the largest Indocyanine Green (CAS 3599-32-4) market with about 52% market share. USA is follower, accounting for about 22% market share.The key manufacturers are Pulsion Medical Systems AG,Dandong Yichuang Pharmaceutical, Diagnostic Green, SERB, Daiichi Sankyo Company, Santen Pharmaceutical, Aurolab, Eisai, etc. Top 3 companies occupied about 60% market share.

Market drivers

Increasing demand for precision medicine

The popularization of fluorescence navigation technology in tumor surgery (such as da Vinci robotic surgery) has made ICG a key reagent for intraoperative imaging. High-incidence tumors such as liver cancer and breast cancer have driven demand (China has more than 400,000 new cases of liver cancer each year).

Technology upgrade and expansion of indications

ICG combined with near-infrared imaging (NIR) technology has been expanded to new scenarios such as lymphangiography and gastrointestinal anastomosis. Nanocarrier technology improves ICG stability and prolongs imaging time (such as tumor-targeted ICG nanoformulations).

Popularization of minimally invasive surgery

The proportion of minimally invasive surgeries such as laparoscopy and thoracoscopy has increased, and the demand for ICG imaging has surged.

This report aims to provide a comprehensive presentation of the global market for Indocyanine Green, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Indocyanine Green by region & country, by Type, and by Application.

The Indocyanine Green market size, estimations, and forecasts are provided in terms of sales volume (K NOS) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Indocyanine Green.

Market Segmentation

By Company

  •     Pulsion Medical Systems AG
  •     Dandong Yichuang Pharmaceutical
  •     Daiichi Sankyo Company
  •     SERB
  •     Santen Pharmaceutical
  •     Diagnostic Green
  •     McKesson Corp
  •     OriFarm
  •     Jeil Pharmaceutical
  •     Aurolab
  •     Cellbion
  •     Eisai

Segment by Type

  •     25mg
  •     50mg

Segment by Application

  •     Ophthalmology
  •     Neurosurgery
  •     Liver Diseases
  •     Others

By Region

North America

  •         United States
  •         Canada

Asia-Pacific

  •         China
  •         Japan
  •         South Korea
  •         Southeast Asia
  •         India
  •         Australia
  •         Rest of Asia-Pacific

Europe

  •         Germany
  •         France
  •         U.K.
  •         Italy
  •         Netherlands
  •         Nordic Countries
  •         Rest of Europe

Latin America

  •         Mexico
  •         Brazil
  •         Rest of Latin America

Middle East & Africa

  •         Turkey
  •         Saudi Arabia
  •         UAE
  •         Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Indocyanine Green manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Indocyanine Green in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Indocyanine Green in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

1.1 Indocyanine Green Product Introduction

1.2 Global Indocyanine Green Market Size Forecast

1.2.1 Global Indocyanine Green Sales Value (2020-2031)

1.2.2 Global Indocyanine Green Sales Volume (2020-2031)

1.2.3 Global Indocyanine Green Sales Price (2020-2031)

1.3 Indocyanine Green Market Trends & Drivers

1.3.1 Indocyanine Green Industry Trends

1.3.2 Indocyanine Green Market Drivers & Opportunity

1.3.3 Indocyanine Green Market Challenges

1.3.4 Indocyanine Green Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Indocyanine Green Players Revenue Ranking (2024)

2.2 Global Indocyanine Green Revenue by Company (2020-2025)

2.3 Global Indocyanine Green Players Sales Volume Ranking (2024)

2.4 Global Indocyanine Green Sales Volume by Company Players (2020-2025)

2.5 Global Indocyanine Green Average Price by Company (2020-2025)

2.6 Key Manufacturers Indocyanine Green Manufacturing Base and Headquarters

2.7 Key Manufacturers Indocyanine Green Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Indocyanine Green

2.9 Indocyanine Green Market Competitive Analysis

2.9.1 Indocyanine Green Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Indocyanine Green Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Indocyanine Green as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 25mg

3.1.2 50mg

3.2 Global Indocyanine Green Sales Value by Type

3.2.1 Global Indocyanine Green Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Indocyanine Green Sales Value, by Type (2020-2031)

3.2.3 Global Indocyanine Green Sales Value, by Type (%) (2020-2031)

3.3 Global Indocyanine Green Sales Volume by Type

3.3.1 Global Indocyanine Green Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Indocyanine Green Sales Volume, by Type (2020-2031)

3.3.3 Global Indocyanine Green Sales Volume, by Type (%) (2020-2031)

3.4 Global Indocyanine Green Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Ophthalmology

4.1.2 Neurosurgery

4.1.3 Liver Diseases

4.1.4 Others

4.2 Global Indocyanine Green Sales Value by Application

4.2.1 Global Indocyanine Green Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Indocyanine Green Sales Value, by Application (2020-2031)

4.2.3 Global Indocyanine Green Sales Value, by Application (%) (2020-2031)

4.3 Global Indocyanine Green Sales Volume by Application

4.3.1 Global Indocyanine Green Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Indocyanine Green Sales Volume, by Application (2020-2031)

4.3.3 Global Indocyanine Green Sales Volume, by Application (%) (2020-2031)

4.4 Global Indocyanine Green Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Indocyanine Green Sales Value by Region

5.1.1 Global Indocyanine Green Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Indocyanine Green Sales Value by Region (2020-2025)

5.1.3 Global Indocyanine Green Sales Value by Region (2026-2031)

5.1.4 Global Indocyanine Green Sales Value by Region (%), (2020-2031)

5.2 Global Indocyanine Green Sales Volume by Region

5.2.1 Global Indocyanine Green Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Indocyanine Green Sales Volume by Region (2020-2025)

5.2.3 Global Indocyanine Green Sales Volume by Region (2026-2031)

5.2.4 Global Indocyanine Green Sales Volume by Region (%), (2020-2031)

5.3 Global Indocyanine Green Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Indocyanine Green Sales Value, 2020-2031

5.4.2 North America Indocyanine Green Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Indocyanine Green Sales Value, 2020-2031

5.5.2 Europe Indocyanine Green Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Indocyanine Green Sales Value, 2020-2031

5.6.2 Asia Pacific Indocyanine Green Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Indocyanine Green Sales Value, 2020-2031

5.7.2 South America Indocyanine Green Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Indocyanine Green Sales Value, 2020-2031

5.8.2 Middle East & Africa Indocyanine Green Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Indocyanine Green Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Indocyanine Green Sales Value and Sales Volume

6.2.1 Key Countries/Regions Indocyanine Green Sales Value, 2020-2031

6.2.2 Key Countries/Regions Indocyanine Green Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Indocyanine Green Sales Value, 2020-2031

6.3.2 United States Indocyanine Green Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Indocyanine Green Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Indocyanine Green Sales Value, 2020-2031

6.4.2 Europe Indocyanine Green Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Indocyanine Green Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Indocyanine Green Sales Value, 2020-2031

6.5.2 China Indocyanine Green Sales Value by Type (%), 2024 VS 2031

6.5.3 China Indocyanine Green Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Indocyanine Green Sales Value, 2020-2031

6.6.2 Japan Indocyanine Green Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Indocyanine Green Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Indocyanine Green Sales Value, 2020-2031

6.7.2 South Korea Indocyanine Green Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Indocyanine Green Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Indocyanine Green Sales Value, 2020-2031

6.8.2 Southeast Asia Indocyanine Green Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Indocyanine Green Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Indocyanine Green Sales Value, 2020-2031

6.9.2 India Indocyanine Green Sales Value by Type (%), 2024 VS 2031

6.9.3 India Indocyanine Green Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Pulsion Medical Systems AG

7.1.1 Pulsion Medical Systems AG Company Information

7.1.2 Pulsion Medical Systems AG Introduction and Business Overview

7.1.3 Pulsion Medical Systems AG Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Pulsion Medical Systems AG Indocyanine Green Product Offerings

7.1.5 Pulsion Medical Systems AG Recent Development

7.2 Dandong Yichuang Pharmaceutical

7.2.1 Dandong Yichuang Pharmaceutical Company Information

7.2.2 Dandong Yichuang Pharmaceutical Introduction and Business Overview

7.2.3 Dandong Yichuang Pharmaceutical Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Dandong Yichuang Pharmaceutical Indocyanine Green Product Offerings

7.2.5 Dandong Yichuang Pharmaceutical Recent Development

7.3 Daiichi Sankyo Company

7.3.1 Daiichi Sankyo Company Company Information

7.3.2 Daiichi Sankyo Company Introduction and Business Overview

7.3.3 Daiichi Sankyo Company Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Daiichi Sankyo Company Indocyanine Green Product Offerings

7.3.5 Daiichi Sankyo Company Recent Development

7.4 SERB

7.4.1 SERB Company Information

7.4.2 SERB Introduction and Business Overview

7.4.3 SERB Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 SERB Indocyanine Green Product Offerings

7.4.5 SERB Recent Development

7.5 Santen Pharmaceutical

7.5.1 Santen Pharmaceutical Company Information

7.5.2 Santen Pharmaceutical Introduction and Business Overview

7.5.3 Santen Pharmaceutical Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Santen Pharmaceutical Indocyanine Green Product Offerings

7.5.5 Santen Pharmaceutical Recent Development

7.6 Diagnostic Green

7.6.1 Diagnostic Green Company Information

7.6.2 Diagnostic Green Introduction and Business Overview

7.6.3 Diagnostic Green Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Diagnostic Green Indocyanine Green Product Offerings

7.6.5 Diagnostic Green Recent Development

7.7 McKesson Corp

7.7.1 McKesson Corp Company Information

7.7.2 McKesson Corp Introduction and Business Overview

7.7.3 McKesson Corp Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 McKesson Corp Indocyanine Green Product Offerings

7.7.5 McKesson Corp Recent Development

7.8 OriFarm

7.8.1 OriFarm Company Information

7.8.2 OriFarm Introduction and Business Overview

7.8.3 OriFarm Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 OriFarm Indocyanine Green Product Offerings

7.8.5 OriFarm Recent Development

7.9 Jeil Pharmaceutical

7.9.1 Jeil Pharmaceutical Company Information

7.9.2 Jeil Pharmaceutical Introduction and Business Overview

7.9.3 Jeil Pharmaceutical Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Jeil Pharmaceutical Indocyanine Green Product Offerings

7.9.5 Jeil Pharmaceutical Recent Development

7.10 Aurolab

7.10.1 Aurolab Company Information

7.10.2 Aurolab Introduction and Business Overview

7.10.3 Aurolab Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Aurolab Indocyanine Green Product Offerings

7.10.5 Aurolab Recent Development

7.11 Cellbion

7.11.1 Cellbion Company Information

7.11.2 Cellbion Introduction and Business Overview

7.11.3 Cellbion Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Cellbion Indocyanine Green Product Offerings

7.11.5 Cellbion Recent Development

7.12 Eisai

7.12.1 Eisai Company Information

7.12.2 Eisai Introduction and Business Overview

7.12.3 Eisai Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Eisai Indocyanine Green Product Offerings

7.12.5 Eisai Recent Development

8 Industry Chain Analysis

8.1 Indocyanine Green Industrial Chain

8.2 Indocyanine Green Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Indocyanine Green Sales Model

8.5.2 Sales Channel

8.5.3 Indocyanine Green Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

Tables and Figures

List of Tables

Table 1. Indocyanine Green Market Trends

Table 2. Indocyanine Green Market Drivers & Opportunity

Table 3. Indocyanine Green Market Challenges

Table 4. Indocyanine Green Market Restraints

Table 5. Global Indocyanine Green Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Indocyanine Green Revenue Market Share by Company (2020-2025)

Table 7. Global Indocyanine Green Sales Volume by Company (2020-2025) & (K NOS)

Table 8. Global Indocyanine Green Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Indocyanine Green Price by Company (2020-2025) & (USD/NOS)

Table 10. Key Manufacturers Indocyanine Green Manufacturing Base and Headquarters

Table 11. Key Manufacturers Indocyanine Green Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Indocyanine Green

Table 13. Global Indocyanine Green Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Indocyanine Green as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Indocyanine Green Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Indocyanine Green Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Indocyanine Green Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Indocyanine Green Sales Market Share in Value by Type (2020-2025)

Table 20. Global Indocyanine Green Sales Market Share in Value by Type (2026-2031)

Table 21. Global Indocyanine Green Sales Volume by Type: 2020 VS 2024 VS 2031 (K NOS)

Table 22. Global Indocyanine Green Sales Volume by Type (2020-2025) & (K NOS)

Table 23. Global Indocyanine Green Sales Volume by Type (2026-2031) & (K NOS)

Table 24. Global Indocyanine Green Sales Volume Market Share by Type (2020-2025)

Table 25. Global Indocyanine Green Sales Volume Market Share by Type (2026-2031)

Table 26. Global Indocyanine Green Price by Type (2020-2025) & (USD/NOS)

Table 27. Global Indocyanine Green Price by Type (2026-2031) & (USD/NOS)

Table 28. Global Indocyanine Green Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Indocyanine Green Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Indocyanine Green Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Indocyanine Green Sales Market Share in Value by Application (2020-2025)

Table 32. Global Indocyanine Green Sales Market Share in Value by Application (2026-2031)

Table 33. Global Indocyanine Green Sales Volume by Application: 2020 VS 2024 VS 2031 (K NOS)

Table 34. Global Indocyanine Green Sales Volume by Application (2020-2025) & (K NOS)

Table 35. Global Indocyanine Green Sales Volume by Application (2026-2031) & (K NOS)

Table 36. Global Indocyanine Green Sales Volume Market Share by Application (2020-2025)

Table 37. Global Indocyanine Green Sales Volume Market Share by Application (2026-2031)

Table 38. Global Indocyanine Green Price by Application (2020-2025) & (USD/NOS)

Table 39. Global Indocyanine Green Price by Application (2026-2031) & (USD/NOS)

Table 40. Global Indocyanine Green Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Indocyanine Green Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Indocyanine Green Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Indocyanine Green Sales Value by Region (2020-2025) & (%)

Table 44. Global Indocyanine Green Sales Value by Region (2026-2031) & (%)

Table 45. Global Indocyanine Green Sales Volume by Region (K NOS): 2020 VS 2024 VS 2031

Table 46. Global Indocyanine Green Sales Volume by Region (2020-2025) & (K NOS)

Table 47. Global Indocyanine Green Sales Volume by Region (2026-2031) & (K NOS)

Table 48. Global Indocyanine Green Sales Volume by Region (2020-2025) & (%)

Table 49. Global Indocyanine Green Sales Volume by Region (2026-2031) & (%)

Table 50. Global Indocyanine Green Average Price by Region (2020-2025) & (USD/NOS)

Table 51. Global Indocyanine Green Average Price by Region (2026-2031) & (USD/NOS)

Table 52. Key Countries/Regions Indocyanine Green Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Indocyanine Green Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Indocyanine Green Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Indocyanine Green Sales Volume, (2020-2025) & (K NOS)

Table 56. Key Countries/Regions Indocyanine Green Sales Volume, (2026-2031) & (K NOS)

Table 57. Pulsion Medical Systems AG Company Information

Table 58. Pulsion Medical Systems AG Introduction and Business Overview

Table 59. Pulsion Medical Systems AG Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS) and Gross Margin (2020-2025)

Table 60. Pulsion Medical Systems AG Indocyanine Green Product Offerings

Table 61. Pulsion Medical Systems AG Recent Development

Table 62. Dandong Yichuang Pharmaceutical Company Information

Table 63. Dandong Yichuang Pharmaceutical Introduction and Business Overview

Table 64. Dandong Yichuang Pharmaceutical Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS) and Gross Margin (2020-2025)

Table 65. Dandong Yichuang Pharmaceutical Indocyanine Green Product Offerings

Table 66. Dandong Yichuang Pharmaceutical Recent Development

Table 67. Daiichi Sankyo Company Company Information

Table 68. Daiichi Sankyo Company Introduction and Business Overview

Table 69. Daiichi Sankyo Company Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS) and Gross Margin (2020-2025)

Table 70. Daiichi Sankyo Company Indocyanine Green Product Offerings

Table 71. Daiichi Sankyo Company Recent Development

Table 72. SERB Company Information

Table 73. SERB Introduction and Business Overview

Table 74. SERB Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS) and Gross Margin (2020-2025)

Table 75. SERB Indocyanine Green Product Offerings

Table 76. SERB Recent Development

Table 77. Santen Pharmaceutical Company Information

Table 78. Santen Pharmaceutical Introduction and Business Overview

Table 79. Santen Pharmaceutical Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS) and Gross Margin (2020-2025)

Table 80. Santen Pharmaceutical Indocyanine Green Product Offerings

Table 81. Santen Pharmaceutical Recent Development

Table 82. Diagnostic Green Company Information

Table 83. Diagnostic Green Introduction and Business Overview

Table 84. Diagnostic Green Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS) and Gross Margin (2020-2025)

Table 85. Diagnostic Green Indocyanine Green Product Offerings

Table 86. Diagnostic Green Recent Development

Table 87. McKesson Corp Company Information

Table 88. McKesson Corp Introduction and Business Overview

Table 89. McKesson Corp Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS) and Gross Margin (2020-2025)

Table 90. McKesson Corp Indocyanine Green Product Offerings

Table 91. McKesson Corp Recent Development

Table 92. OriFarm Company Information

Table 93. OriFarm Introduction and Business Overview

Table 94. OriFarm Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS) and Gross Margin (2020-2025)

Table 95. OriFarm Indocyanine Green Product Offerings

Table 96. OriFarm Recent Development

Table 97. Jeil Pharmaceutical Company Information

Table 98. Jeil Pharmaceutical Introduction and Business Overview

Table 99. Jeil Pharmaceutical Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS) and Gross Margin (2020-2025)

Table 100. Jeil Pharmaceutical Indocyanine Green Product Offerings

Table 101. Jeil Pharmaceutical Recent Development

Table 102. Aurolab Company Information

Table 103. Aurolab Introduction and Business Overview

Table 104. Aurolab Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS) and Gross Margin (2020-2025)

Table 105. Aurolab Indocyanine Green Product Offerings

Table 106. Aurolab Recent Development

Table 107. Cellbion Company Information

Table 108. Cellbion Introduction and Business Overview

Table 109. Cellbion Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS) and Gross Margin (2020-2025)

Table 110. Cellbion Indocyanine Green Product Offerings

Table 111. Cellbion Recent Development

Table 112. Eisai Company Information

Table 113. Eisai Introduction and Business Overview

Table 114. Eisai Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS) and Gross Margin (2020-2025)

Table 115. Eisai Indocyanine Green Product Offerings

Table 116. Eisai Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Indocyanine Green Downstream Customers

Table 120. Indocyanine Green Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Indocyanine Green Product Picture

Figure 2. Global Indocyanine Green Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Indocyanine Green Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Indocyanine Green Sales Volume (2020-2031) & (K NOS)

Figure 5. Global Indocyanine Green Sales Price (2020-2031) & (USD/NOS)

Figure 6. Indocyanine Green Report Years Considered

Figure 7. Global Indocyanine Green Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Indocyanine Green Players Sales Volume Ranking (2024) & (K NOS)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Indocyanine Green Revenue in 2024

Figure 10. Indocyanine Green Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. 25mg Picture

Figure 12. 50mg Picture

Figure 13. Global Indocyanine Green Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Indocyanine Green Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Indocyanine Green Sales Volume by Type (2020 VS 2024 VS 2031) & (K NOS)

Figure 16. Global Indocyanine Green Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Indocyanine Green Price by Type (2020-2031) & (USD/NOS)

Figure 18. Product Picture of Ophthalmology

Figure 19. Product Picture of Neurosurgery

Figure 20. Product Picture of Liver Diseases

Figure 21. Product Picture of Others

Figure 22. Global Indocyanine Green Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 23. Global Indocyanine Green Sales Value Market Share by Application, 2024 & 2031

Figure 24. Global Indocyanine Green Sales Volume by Application (2020 VS 2024 VS 2031) & (K NOS)

Figure 25. Global Indocyanine Green Sales Volume Market Share by Application, 2024 & 2031

Figure 26. Global Indocyanine Green Price by Application (2020-2031) & (USD/NOS)

Figure 27. North America Indocyanine Green Sales Value (2020-2031) & (US$ Million)

Figure 28. North America Indocyanine Green Sales Value by Country (%), 2024 VS 2031

Figure 29. Europe Indocyanine Green Sales Value, (2020-2031) & (US$ Million)

Figure 30. Europe Indocyanine Green Sales Value by Country (%), 2024 VS 2031

Figure 31. Asia Pacific Indocyanine Green Sales Value, (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Indocyanine Green Sales Value by Region (%), 2024 VS 2031

Figure 33. South America Indocyanine Green Sales Value, (2020-2031) & (US$ Million)

Figure 34. South America Indocyanine Green Sales Value by Country (%), 2024 VS 2031

Figure 35. Middle East & Africa Indocyanine Green Sales Value, (2020-2031) & (US$ Million)

Figure 36. Middle East & Africa Indocyanine Green Sales Value by Country (%), 2024 VS 2031

Figure 37. Key Countries/Regions Indocyanine Green Sales Value (%), (2020-2031)

Figure 38. Key Countries/Regions Indocyanine Green Sales Volume (%), (2020-2031)

Figure 39. United States Indocyanine Green Sales Value, (2020-2031) & (US$ Million)

Figure 40. United States Indocyanine Green Sales Value by Type (%), 2024 VS 2031

Figure 41. United States Indocyanine Green Sales Value by Application (%), 2024 VS 2031

Figure 42. Europe Indocyanine Green Sales Value, (2020-2031) & (US$ Million)

Figure 43. Europe Indocyanine Green Sales Value by Type (%), 2024 VS 2031

Figure 44. Europe Indocyanine Green Sales Value by Application (%), 2024 VS 2031

Figure 45. China Indocyanine Green Sales Value, (2020-2031) & (US$ Million)

Figure 46. China Indocyanine Green Sales Value by Type (%), 2024 VS 2031

Figure 47. China Indocyanine Green Sales Value by Application (%), 2024 VS 2031

Figure 48. Japan Indocyanine Green Sales Value, (2020-2031) & (US$ Million)

Figure 49. Japan Indocyanine Green Sales Value by Type (%), 2024 VS 2031

Figure 50. Japan Indocyanine Green Sales Value by Application (%), 2024 VS 2031

Figure 51. South Korea Indocyanine Green Sales Value, (2020-2031) & (US$ Million)

Figure 52. South Korea Indocyanine Green Sales Value by Type (%), 2024 VS 2031

Figure 53. South Korea Indocyanine Green Sales Value by Application (%), 2024 VS 2031

Figure 54. Southeast Asia Indocyanine Green Sales Value, (2020-2031) & (US$ Million)

Figure 55. Southeast Asia Indocyanine Green Sales Value by Type (%), 2024 VS 2031

Figure 56. Southeast Asia Indocyanine Green Sales Value by Application (%), 2024 VS 2031

Figure 57. India Indocyanine Green Sales Value, (2020-2031) & (US$ Million)

Figure 58. India Indocyanine Green Sales Value by Type (%), 2024 VS 2031

Figure 59. India Indocyanine Green Sales Value by Application (%), 2024 VS 2031

Figure 60. Indocyanine Green Industrial Chain

Figure 61. Indocyanine Green Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed